Dachaigh › Siostam Immune agus Galaran › Massachusetts › Boston
Sgrùdaidhean clionaigeach Siostam Immune agus Galaran ann an Boston, MA
Tha 10 sgrùdaidhean airson Siostam Immune agus Galaran a’ lorg phàirtichean aig làraichean ann agus timcheall air Boston (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
A’ fastadhÌre 1
- Beth Israel Deaconess Medical Center - Research, Boston
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
A’ fastadhÌre 3
- Massachusetts General Hospital, Boston
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
A’ fastadhSgrùdadh amharc
- Brigham and Women's Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
A’ fastadhÌre 2
- Dana-Farber Cancer Institute, Boston
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
A’ fastadhÌre 3
- Massachusetts General Hospital, Boston
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
A’ fastadhÌre 1
- Massachusetts General Hospital, Boston
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
A’ fastadhÌre 1/2
- Massachusetts General Hospital, Boston
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
A’ fastadhÌre 1/2
- Brigham and Women's Hospital, Boston
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
A’ fastadhÌre 1/2
- Dana Farber Cancer Institute, Boston
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
A’ fastadhÌre 2
- Dana-Farber Cancer Institute, Boston
Sgrùdaidhean Siostam Immune agus Galaran ann am bailtean eile
- Washington, DC13 sgrùdaidhean
- New York City, NY12 sgrùdaidhean
- Philadelphia, PA10 sgrùdaidhean
- Atlanta, GA9 sgrùdaidhean
- Portland, OR9 sgrùdaidhean
- Houston, TX9 sgrùdaidhean
- Cleveland, OH8 sgrùdaidhean
- Chicago, IL8 sgrùdaidhean
- Los Angeles, CA8 sgrùdaidhean
- Cedar Rapids, IA6 sgrùdaidhean
- Milwaukee, WI6 sgrùdaidhean
- Seattle, WA6 sgrùdaidhean
Sgrùdaidhean eile ann an Boston
- Aillse a' bhroilleach111 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag90 sgrùdaidhean
- Aillse (gach seòrsa)86 sgrùdaidhean
- Aillse colorectal63 sgrùdaidhean
- Ailse metastatach63 sgrùdaidhean
- Ailseachadh nan Sgamhan62 sgrùdaidhean
- Cancer Ovarian61 sgrùdaidhean
- Aillse Prostata59 sgrùdaidhean
- Depression52 sgrùdaidhean
- Ailse Endometrial50 sgrùdaidhean
- Fàilligeadh a' Chridhe44 sgrùdaidhean
- Leukemia myeloid geur44 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.